IMMUNE NETWORK

The Korean Association of Immunobiologists (대한면역학회)
권호 표지
DOI QR코드

DOI QR Code

Identification of CCL1 as a Gene Differentially Expressed in $CD4^+$ T cells Expressing TIM-3

  • Jun, Ka-Jung (Department of Microbiology, Ajou University School of Medicine) ;
  • Lee, Mi-Jin (Department of Microbiology, Ajou University School of Medicine) ;
  • Shin, Dong-Chul (Department of Microbiology, Ajou University School of Medicine) ;
  • Woo, Min-Yeong (Department of Microbiology, Ajou University School of Medicine) ;
  • Kim, Kyong-Min (Department of Microbiology, Ajou University School of Medicine) ;
  • Park, Sun (Department of Microbiology, Ajou University School of Medicine)
  • Received : 2011.06.23
  • Accepted : 2011.07.15
  • Published : 2011.08.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: T cell immunoglobulin mucin containing molecule (TIM)-3 is expressed in differentiated Th1 cells and is involved in the suppression of the cytokine production by these cells. However, the regulation of the expression of other T cell genes by TIM-3 is unclear. Herein, we attempted to identify differentially expressed genes in cells abundantly expressing TIM-3 compared to cells with low expression of TIM-3. Methods: TIM-3 overexpressing cell clones were established by transfection of Jurkat T cells with TIM-3 expression vector. For screening of differentially expressed genes, gene fishing technology based on reverse transcription-polymerase chain reaction (RT-PCR) using an annealing control primer system was used. The selected candidate genes were validated by semi quantitative and real-time RT-PCR. Results: The transcription of TIMP-1, IFITM1, PAR3 and CCL1 was different between TIM-3 overexpressing cells and control cells. However, only CCL1 transcription was significantly different in cells transiently transfected with TIM3 expression vector compared with control cells. CCL1 transcription was increased in primary human $CD4^+$ T cells abundantly expressing TIM-3 but not in cells with low expression of TIM-3. Conclusion: CCL1 was identified as a differentially transcribed gene in TIM-3-expressing $CD4^+$ T cells.

Keywords

References

  1. Anderson AC, Anderson DE: TIM-3 in autoimmunity. Curr Opin Immunol 18:665-9, 2006. https://doi.org/10.1016/j.coi.2006.09.009
  2. Sabatos CA, Chakravarti S, Cha E, Schubart A, Sanchez-Fueyo A, Zheng XX, Coyle AJ, Strom TB, Freeman GJ, Kuchroo VK: Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 4:1102-10, 2003. https://doi.org/10.1038/ni988
  3. Lee MJ, Woo MY, Heo YM, Kim JS, Kwon MH, Kim K, Park S: The inhibition of the T-cell immunoglobulin and mucin domain 3 (Tim3) pathway enhances the efficacy of tumor vaccine. Biochem Biophys Res Commun 402:88-93, 2010. https://doi.org/10.1016/j.bbrc.2010.09.121
  4. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Manning S, Greenfield EA, Coyle AJ, Sobel RA, Freeman GJ, Kuchroo VK: Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415:536-41, 2002. https://doi.org/10.1038/415536a
  5. Sanchez-Fueyo A, Tian J, Picarella D, Domenig C, Zheng XX, Sabatos CA, Manlongat N, Bender O, Kamradt T, Kuchroo VK, Gutiérrez-Ramos JC, Coyle AJ, Strom TB: Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 4:1093-101, 2003. https://doi.org/10.1038/ni987
  6. Liu Y, Shu Q, Gao L, Hou N, Zhao D, Liu X, Zhang X, Xu L, Yue X, Zhu F, Guo C, Liang X, Ma C: Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity. Clin Immunol 137:288-95, 2010. https://doi.org/10.1016/j.clim.2010.07.012
  7. Yang L, Anderson DE, Kuchroo J, Hafler DA: Lack of TIM-3 immunoregulation in multiple sclerosis. J Immunol 180:4409-14, 2008. https://doi.org/10.4049/jimmunol.180.7.4409
  8. Morimoto K, Hosomi S, Yamagami H, Watanabe K, Kamata N, Sogawa M, Machida H, Okazaki H, Tanigawa T, Nagahara H, Noda E, Tominaga K, Watanabe T, Fujiwara Y, Maeda K, Hirakawa K, Arakawa T: Dysregulated upregulation of T-cell immunoglobulin and mucin domain-3 on mucosal T helper 1 cells in patients with Crohn's disease. Scand J Gastroenterol 46:701-9, 2011. https://doi.org/10.3109/00365521.2011.568518
  9. Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S, Stevens RL, Hirashima M: Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 273:16976-84, 1998. https://doi.org/10.1074/jbc.273.27.16976
  10. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB, Kuchroo VK: The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6:1245-52, 2005. https://doi.org/10.1038/ni1271
  11. DeKruyff RH, Bu X, Ballesteros A, Santiago C, Chim YL, Lee HH, Karisola P, Pichavant M, Kaplan GG, Umetsu DT, Freeman GJ, Casasnovas JM: T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. J Immunol 184:1918-30, 2010. https://doi.org/10.4049/jimmunol.0903059
  12. Iellem A, Colantonio L, Bhakta S, Sozzani S, Mantovani A, Sinigaglia F, D'Ambrosio D: Inhibition by IL-12 and IFN-alpha of I-309 and macrophage-derived chemokine production upon TCR triggering of human Th1 cells. Eur J Immunol 30:1030-9, 2000. https://doi.org/10.1002/(SICI)1521-4141(200004)30:4<1030::AID-IMMU1030>3.0.CO;2-8
  13. Su SB, Grajewski RS, Luger D, Agarwal RK, Silver PB, Tang J, Tuo J, Chan CC, Caspi RR: Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency. Invest Ophthalmol Vis Sci 48:4616-25, 2007. https://doi.org/10.1167/iovs.07-0233
  14. Selvan RS, Zhou LJ, Krangel MS: Regulation of I-309 gene expression in human monocytes by endogenous interleukin-1. Eur J Immunol 27:687-94, 1997. https://doi.org/10.1002/eji.1830270317
  15. Gonzalo JA, Qiu Y, Lora JM, Al-Garawi A, Villeval JL, Boyce JA, Martinez-A C, Marquez G, Goya I, Hamid Q, Fraser CC, Picarella D, Cote-Sierra J, Hodge MR, Gutierrez-Ramos JC, Kolbeck R, Coyle AJ: Coordinated involvement of mast cells and T cells in allergic mucosal inflammation: critical role of the CC chemokine ligand 1:CCR8 axis. J Immunol 179:1740-50, 2007. https://doi.org/10.4049/jimmunol.179.3.1740
  16. Zingoni A, Soto H, Hedrick JA, Stoppacciaro A, Storlazzi CT, Sinigaglia F, D'Ambrosio D, O'Garra A, Robinson D, Rocchi M, Santoni A, Zlotnik A, Napolitano M: The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 161:547-51, 1998.
  17. Sebastiani S, Allavena P, Albanesi C, Nasorri F, Bianchi G, Traidl C, Sozzani S, Girolomoni G, Cavani A: Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol 166:996-1002, 2001. https://doi.org/10.4049/jimmunol.166.2.996
  18. Montes-Vizuet R, Vega-Miranda A, Valencia-Maqueda E, Negrete-García MC, Velasquez JR, Teran LM: CC chemokine ligand 1 is released into the airways of atopic asthmatics. Eur Respir J 28:59-67, 2006. https://doi.org/10.1183/09031936.06.00134304
  19. Gombert M, Dieu-Nosjean MC, Winterberg F, Bunemann E, Kubitza RC, Da Cunha L, Haahtela A, Lehtimaki S, Muller A, Rieker J, Meller S, Pivarcsi A, Koreck A, Fridman WH, Zentgraf HW, Pavenstadt H, Amara A, Caux C, Kemeny L, Alenius H, Lauerma A, Ruzicka T, Zlotnik A, Homey B: CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol 174:5082-91, 2005. https://doi.org/10.4049/jimmunol.174.8.5082
  20. Soler D, Chapman TR, Poisson LR, Wang L, Cote-Sierra J, Ryan M, McDonald A, Badola S, Fedyk E, Coyle AJ, Hodge MR, Kolbeck R: CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes. J Immunol 177:6940-51, 2006. https://doi.org/10.4049/jimmunol.177.10.6940
  21. Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, D'Ambrosio D: Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 194:847-53, 2001. https://doi.org/10.1084/jem.194.6.847
  22. Hoshino A, Kawamura YI, Yasuhara M, Toyama-Sorimachi N, Yamamoto K, Matsukawa A, Lira SA, Dohi T: Inhibition of CCL1-CCR8 interaction prevents aggregation of macrophages and development of peritoneal adhesions. J Immunol 178:5296-304, 2007. https://doi.org/10.4049/jimmunol.178.8.5296
  23. Hastings WD, Anderson DE, Kassam N, Koguchi K, Greenfield EA, Kent SC, Zheng XX, Strom TB, Hafler DA, Kuchroo VK: TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur J Immunol 39:2492-501, 2009. https://doi.org/10.1002/eji.200939274

Cited by

  1. The Possible Diagnostic and Prognostic Use of Systemic Chemokine Profiles in Clinical Medicine—The Experience in Acute Myeloid Leukemia from Disease Development and Diagnosis via Conventional C vol.5, pp.2, 2013, https://doi.org/10.3390/toxins5020336
  2. miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma vol.35, pp.3, 2021, https://doi.org/10.1038/s41375-020-0947-1